ARTICLE | Financial News
Harpoon raises $70M ahead of additional Phase I starts for TriTACs
November 16, 2018 3:57 PM UTC
Harpoon Therapeutics Inc. (South San Francisco, Calif.) raised $70 million on Nov. 11 in a series C round led by new investor OrbiMed Advisors, as the immunotherapy company gears up to bring two more of its T cell engagers into clinic next year.
Harpoon CFO Georgia Erbez told BioCentury the financing provides about two years of runway...